Free access

Research Article

17 February 2021

Endovascular treatment with the Enterprise stent versus the Neuroform or Low-Profile Visualized Intraluminal Support stent for unruptured aneurysms

Authors: Reade De Leacy, Emilie Kottenmeier, Stephanie HY Lee, Rahul Khanna [email protected], and Alejandro M SpiottaAuthor Info & Affiliations

Publication: Journal of Comparative Effectiveness Research

Volume 10, Number 4

https://doi.org/10.2217/cer-2020-0202

PDF OtherFormats

Abstract

Aim: To compare outcomes among patients undergoing endovascular treatment for unruptured intracranial aneurysm (UIA) with the Enterprise stent versus the Neuroform or Low-Profile Visualized Intraluminal Support (LVIS) stent. Patients & methods: Patients undergoing endovascular procedure for UIA were classified into Enterprise stent and Neuroform or LVIS stent group. Groups were propensity-score matched and generalized estimating equations were used for outcomes assessment. Results: There were no significant between-group differences in length of stay or mortality. The Enterprise group had significantly lower odds of UIA-related inpatient readmissions versus the Neuroform/LVIS group (odds ratio: 0.62; 95% CI: 0.42–0.91). Conclusion: Enterprise stent use was associated with significantly lower readmissions versus competitor stent, with no difference in other study outcomes.

Supplementary Material

File (supplementary table 1.docx)

Download
13.14 KB

References

Papers of special note have been highlighted as: •• of considerable interest

1.

Lasheras JC. The biomechanics of arterial aneurysms. Annu. Rev. Fluid. Mech. 39, 293–319 (2007).

2.

Vlak MH, Algra A, Brandenburg R et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 10(7), 626–636 (2011).

3.

Korja M, Lehto H, Juvela S. Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study. Stroke 45(7), 1958–1963 (2014).

4.

Li ZQ, Wang QH, Chen G et al. Outcomes of endovascular coiling versus surgical clipping in the treatment of ruptured intracranial aneurysms. J. Int. Med. Res. 40(6), 2145–2151 (2012).

5.

Cognard C, Weill A, Spelle L et al. Long-term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils. Radiology 212(2), 348–356 (1999).

6.

Fernandez Zubillaga A, Guglielmi G, Vinuela F et al. Endovascular occlusion of intracranial aneurysms with electrically detachable coils: correlation of aneurysm neck size and treatment results. Am. J. Neuroradiol. 15(5), 815–820 (1994).

7.

Murayama Y, Nien YL, Duckwiler G et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years’ experience. J. Neurosurg. 98(5), 959–966 (2003).

8.

Kadkhodayan Y, Rhodes N, Blackburn S et al. Comparison of Enterprise with Neuroform stent-assisted coiling of intracranial aneurysms. Am. J. Roentgenol. 200(4), 872–878 (2013).

•• Enterprise stent use was associated with statistically significant superior deployment rate and occlusion rate as compared with Neuroform stent.

9.

Cho SH, Jo WI, Jo YE et al. Bench-top comparison of physical properties of 4 commercially-available self-expanding intracranial stents. Neurointervention 12(1), 31–39 (2017).

10.

Ge H, Lv X, Yang X et al. LVIS stent versus Enterprise stent for the treatment of unruptured intracranial aneurysms. World Neurosurg. 91, 365–370 (2016).

•• Showed no significant difference in modified Rankin Scale score and procedural complications between Enterprise stent and Low-profile Visualized Intraluminal Support stent among unruptured intracranial aneurysms patients.

11.

Durst CR, Khan P, Gaughen J et al. Direct comparison of Neuroform and Enterprise stents in the treatment of wide-necked intracranial aneurysms. Clin. Radiol. 69(12), 471–476 (2014).

•• Neuroform stent was found to be a predictor of retreatment, with no difference observed in occlusion rate compared with Enterprise stent.

12.

Wang J, Vargas J, Spiotta A et al. Stent-assisted coiling of cerebral aneurysms: a single-center clinical and angiographic analysis. J. Neurointerv. Surg. 10(7), 687–692 (2018).

13.

Premier Applied Sciences. Premier Healthcare Database White Paper: Data that Informs and Performs (2020). https://products.premierinc.com/downloads/PremierHealthcareDatabaseWhitepaper.pdf

14.

de Groot V, Beckerman H, Lankhorst GJ et al. How to measure comorbidity: a critical review of available methods. J. Clin. Epidemiol. 56, 221–229 (2003).

15.

Mokin M, Primiani CT, Ren Z et al. Stent-assisted coiling of cerebral aneurysms: multi-center analysis of radiographic and clinical outcomes in 659 patients. J. Neurointerv. Surg. 12(3), 289–297 (2020).

16.

Kono K, Terada T. In vitro experiments of vessel wall apposition between the Enterprise and Enterprise 2 stents for treatment of cerebral aneurysms. Acta Neurochirurgica 158(2), 241–245 (2016).

17.

Jankowitz BT, Hanel R, Jadhav AP et al. Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort. J. Neurointerv. Surg. 11(8), 801–806 (2019).

18.

Gupta M, Cheung VJ, Abraham P et al. Low-profile visualized intraluminal support junior device for the treatment of intracranial aneurysms. Cureus 9, 2 (2017).

|